<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="by reducing reactive oxygen species and increasing antioxidants, and ameliorate" exact="nitric oxide" post="bioavailability, endothelial function, and integrity. Most of these effects"/>
 <result pre="of symptoms in statin-naÃ¯ve patients hospitalized for seasonal influenza receiving" exact="atorvastatin" post="40 mg compared with placebo. An association between outpatient"/>
 <result pre="a proinflammatory trigger such as hypoxia.8 Moreover, in murine cells," exact="atorvastatin" post="0.1 Î¼M (corresponding to the plasma concentration obtained with"/>
 <result pre="administration of CYP3A4 inhibitors currently used in COVID-19, such as" exact="ritonavir" post="and cobicistat, could increase the risk of muscle and"/>
 <result pre="therefore, starting with a lower dose of statin and monitoring" exact="creatine" post="kinase and transaminases would be advisable in these cases."/>
</results>
